Breeaking: Polyrizon Ltd. ($PLRZ) Gearing for 200% SpikeThe price Polyrizon Ltd. (NASDAQ; NASDAQ:PLRZ ) experience a notable spike of over 120% in early premarket trading on Thursday breaking out of a bullish symmetrical triangle .
The share price is enroute to the $20 resistant eyeing a whooping 200% spike today. last recorded RSI was 65 further cementing NASDAQ:PLRZ bullish momentum.
In another news, Polyrizon Ltd. (Nasdaq: PLRZ) announced compelling new preclinical data showing its proprietary naloxone hydrogel adheres to nasal tissue longer than an approved and marketed intranasal naloxone spray product.
The results showed that Polyrizon’s Trap and Target ™ (T&T) hydrogel exhibited significantly higher mucoadhesion levels compared to the commercial product, supporting potentially prolonged contact at the nasal deposition site and potentially enhancing bioavailability.
About PLRZ
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers.
